These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 25479829)
21. H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas. Gielen GH; Gessi M; Hammes J; Kramm CM; Waha A; Pietsch T Am J Clin Pathol; 2013 Mar; 139(3):345-9. PubMed ID: 23429371 [TBL] [Abstract][Full Text] [Related]
22. The Daxx/Atrx Complex Protects Tandem Repetitive Elements during DNA Hypomethylation by Promoting H3K9 Trimethylation. He Q; Kim H; Huang R; Lu W; Tang M; Shi F; Yang D; Zhang X; Huang J; Liu D; Songyang Z Cell Stem Cell; 2015 Sep; 17(3):273-86. PubMed ID: 26340527 [TBL] [Abstract][Full Text] [Related]
23. New players in heterochromatin silencing: histone variant H3.3 and the ATRX/DAXX chaperone. Voon HP; Wong LH Nucleic Acids Res; 2016 Feb; 44(4):1496-501. PubMed ID: 26773061 [TBL] [Abstract][Full Text] [Related]
24. Correlation Between Immunohistochemistry and Sequencing in H3G34-Mutant Gliomas. Gianno F; Antonelli M; Di Dio T; Minasi S; Donofrio V; Buccoliero AM; Gardiman MP; Pollo B; Diomedi Camassei F; Rossi S; Novello M; Giangaspero F; Arcella A; Gessi M; Buttarelli FR Am J Surg Pathol; 2021 Feb; 45(2):200-204. PubMed ID: 33428336 [TBL] [Abstract][Full Text] [Related]
25. Genome-wide ChIP-seq analysis of EZH2-mediated H3K27me3 target gene profile highlights differences between low- and high-grade astrocytic tumors. Sharma V; Malgulwar PB; Purkait S; Patil V; Pathak P; Agrawal R; Kulshreshtha R; Mallick S; Julka PK; Suri A; Sharma BS; Suri V; Sharma MC; Sarkar C Carcinogenesis; 2017 Feb; 38(2):152-161. PubMed ID: 27993893 [TBL] [Abstract][Full Text] [Related]
26. Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques. Wierda RJ; Rietveld IM; van Eggermond MC; Belien JA; van Zwet EW; Lindeman JH; van den Elsen PJ Life Sci; 2015 May; 129():3-9. PubMed ID: 25445221 [TBL] [Abstract][Full Text] [Related]
27. The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9. Dhayalan A; Tamas R; Bock I; Tattermusch A; Dimitrova E; Kudithipudi S; Ragozin S; Jeltsch A Hum Mol Genet; 2011 Jun; 20(11):2195-203. PubMed ID: 21421568 [TBL] [Abstract][Full Text] [Related]
28. Distinct Histomorphology in Molecular Subgroups of Glioblastomas in Young Patients. Neumann JE; Dorostkar MM; Korshunov A; Mawrin C; Koch A; Giese A; Schüller U J Neuropathol Exp Neurol; 2016 May; 75(5):408-14. PubMed ID: 26975364 [TBL] [Abstract][Full Text] [Related]
29. Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Bender S; Tang Y; Lindroth AM; Hovestadt V; Jones DT; Kool M; Zapatka M; Northcott PA; Sturm D; Wang W; Radlwimmer B; Højfeldt JW; Truffaux N; Castel D; Schubert S; Ryzhova M; Seker-Cin H; Gronych J; Johann PD; Stark S; Meyer J; Milde T; Schuhmann M; Ebinger M; Monoranu CM; Ponnuswami A; Chen S; Jones C; Witt O; Collins VP; von Deimling A; Jabado N; Puget S; Grill J; Helin K; Korshunov A; Lichter P; Monje M; Plass C; Cho YJ; Pfister SM Cancer Cell; 2013 Nov; 24(5):660-72. PubMed ID: 24183680 [TBL] [Abstract][Full Text] [Related]
30. Effects of H3.3G34V mutation on genomic H3K36 and H3K27 methylation patterns in isogenic pediatric glioma cells. Huang TY; Piunti A; Qi J; Morgan M; Bartom E; Shilatifard A; Saratsis AM Acta Neuropathol Commun; 2020 Dec; 8(1):219. PubMed ID: 33287886 [TBL] [Abstract][Full Text] [Related]
31. Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs. Jha P; Agrawal R; Pathak P; Kumar A; Purkait S; Mallik S; Suri V; Chand Sharma M; Gupta D; Suri A; Sharma BS; Julka PK; Kulshreshtha R; Sarkar C Int J Cancer; 2015 Nov; 137(10):2343-53. PubMed ID: 25994230 [TBL] [Abstract][Full Text] [Related]
32. Biomarker-driven diagnosis of diffuse gliomas. Appin CL; Brat DJ Mol Aspects Med; 2015 Nov; 45():87-96. PubMed ID: 26004297 [TBL] [Abstract][Full Text] [Related]
33. Cerebral hemispheric glioblastoma with PNET-like morphology and histone H3.3 G34 mutation in younger patients: Report of three rare cases and diagnostic pitfalls. Cheng Y; Bao W; Wu Q Indian J Pathol Microbiol; 2020; 63(2):262-266. PubMed ID: 32317528 [TBL] [Abstract][Full Text] [Related]
34. ATRX promotes gene expression by facilitating transcriptional elongation through guanine-rich coding regions. Levy MA; Kernohan KD; Jiang Y; Bérubé NG Hum Mol Genet; 2015 Apr; 24(7):1824-35. PubMed ID: 25452430 [TBL] [Abstract][Full Text] [Related]
35. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors. Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329 [TBL] [Abstract][Full Text] [Related]
36. Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG). Giagnacovo M; Antonelli M; Biassoni V; Schiavello E; Warmuth-Metz M; Buttarelli FR; Modena P; Massimino M Childs Nerv Syst; 2020 Apr; 36(4):697-704. PubMed ID: 31848724 [TBL] [Abstract][Full Text] [Related]
37. ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome. Iwase S; Xiang B; Ghosh S; Ren T; Lewis PW; Cochrane JC; Allis CD; Picketts DJ; Patel DJ; Li H; Shi Y Nat Struct Mol Biol; 2011 Jun; 18(7):769-76. PubMed ID: 21666679 [TBL] [Abstract][Full Text] [Related]
38. ATRX Plays a Key Role in Maintaining Silencing at Interstitial Heterochromatic Loci and Imprinted Genes. Voon HP; Hughes JR; Rode C; De La Rosa-Velázquez IA; Jenuwein T; Feil R; Higgs DR; Gibbons RJ Cell Rep; 2015 Apr; 11(3):405-18. PubMed ID: 25865896 [TBL] [Abstract][Full Text] [Related]
39. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618 [TBL] [Abstract][Full Text] [Related]
40. GBM-associated mutations and altered protein expression are more common in young patients. Ferguson SD; Xiu J; Weathers SP; Zhou S; Kesari S; Weiss SE; Verhaak RG; Hohl RJ; Barger GR; Reddy SK; Heimberger AB Oncotarget; 2016 Oct; 7(43):69466-69478. PubMed ID: 27579614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]